Japan-Singapore Research Collaboration To Tackle Eye Diseases
Tech & Pharma
July 17, 2013
A Japan-Singapore research collaboration has been set up to develop technologies that can better detect major eye disorders and diseases.
Asian Scientist (Jul. 17, 2013) - Japan’s Topcon Corporation and Singapore’s Institute for Infocomm Research (I2R) have set up a joint laboratory to develop advanced technologies that can better detect major eye disorders and diseases such as myopia, glaucoma, and age-related macular degeneration (AMD).
The research collaboration, called the ATLANTIA (Advanced Technological Laboratory for A*STAR aNd Topcon’s Innovative Alliance), will leverage on the expertise and capabilities of I2R’s Ocular Imaging Program and Topcon Corporation, a leading ophthalmic instruments and optometrics instruments manufacturer worldwide.
The aim of the collaboration is to develop automated intelligent technologies aimed at improving accuracy of detection and reducing the time taken to detect eye diseases and disorders. These technologies will be able to automatically process and analyse eye images captured by ocular imaging equipment.
The technology will be especially useful for detecting eye diseases such as glaucoma, a disorder that leads to blindness but shows no symptoms in the early stage, making early detection difficult.
It is hoped that, by embedding the technology in eye screening machines, screening of glaucoma, myopia and AMD can be done during routine eye checks at hospitals and at optical shops. This will facilitate regular eye examinations which are essential for early detection and diagnosis of such disorders.
“Our eyes are the windows to the world. Early detection of eye diseases such as glaucoma, myopia and age-related macular degeneration can potentially reduce healthcare costs and prevent and reduce pain and suffering for the patients,” said Dr. Tan Geok Leng, Executive Director of I2R.
A cloud-based data management system will also be co-developed in the joint laboratory to provide more widespread access for doctors, opticians and patients.
Source: A*STAR; Photo: Doug Waldron/Flickr.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.